FMP
Regencell Bioscience Holdings Limited
RGC
NASDAQ
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
12.62 USD
-1.47 (-11.65%)
About
ceo
Mr. Yat-Gai Au
sector
Healthcare
industry
Drug Manufacturers - Specialty & Generic
exchange
NASDAQ
Description
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
CIK
0001829667
ISIN
KYG7487R1002
CUSIP
G7487R100
Address
First Commercial Building
Phone
852 2155 0823
Country
HK
Employee
12
IPO Date
Jul 16, 2021
Key Executives
Name
Title
Pay
Year Born
Mr. Yat-Gai Au
Founder, Chairman & Chief Executive Offi...
0
1973
Ms. Antonia Assang
Senior Vice President of Project Managem...
0
N/A
Ms. Michelle Chan
Financial Controller & Principal Financi...
0
N/A
Mr. Wai Hong Chung
Chief Operating Officer, Chief Strategy ...
245.64k
1977
Mr. Yat-Pui Au
Chief Business Officer
0
1974
As of December 31, 2024, the total employee count stands at 12, with compensation values reflecting the last fiscal year ending on that date. Pay encompasses salary, bonuses, etc., All figures are in USD.
